This trial is terminated!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Burns
and you are
between 5 and 22
years old
Phase
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The specific aims of this investigation in children during burn rehabilitation include 1.) to determine the efficacy of melatonin intervention on improving sleep-related outcomes 2.) investigate the hypothesis that sleep inadequacy is associated with cognitive deficits and 3.) develop a new methodology specific for burn patients that accurately screens for the presence of intrinsic dyssomnia.

Provided treatments

  • Drug: Melatonin
  • Other: placebo
Tris trial is registered with FDA with number: NCT01598259. The sponsor of the trial is Shriners Hospitals for Children and it is looking for 10 volunteers for the current phase.
Official trial title:
Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation